These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24882529)

  • 1. Greater mortality risk among patients with delayed follow-up after implantable cardioverter defibrillator procedures.
    Laksman ZW; Krahn AD; Dorian P; Simpson CS; Crystal E; Healey JS; Khaykin Y; Wang X; Lee DS
    Can J Cardiol; 2014 Jun; 30(6):598-605. PubMed ID: 24882529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex differences in implantable cardioverter-defibrillator outcomes: findings from a prospective defibrillator database.
    MacFadden DR; Crystal E; Krahn AD; Mangat I; Healey JS; Dorian P; Birnie D; Simpson CS; Khaykin Y; Pinter A; Nanthakumar K; Calzavara AJ; Austin PC; Tu JV; Lee DS
    Ann Intern Med; 2012 Feb; 156(3):195-203. PubMed ID: 22312139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of early complications related to De Novo cardioverter defibrillator implantation insights from the Ontario ICD database.
    Lee DS; Krahn AD; Healey JS; Birnie D; Crystal E; Dorian P; Simpson CS; Khaykin Y; Cameron D; Janmohamed A; Yee R; Austin PC; Chen Z; Hardy J; Tu JV;
    J Am Coll Cardiol; 2010 Feb; 55(8):774-82. PubMed ID: 20170816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival after implantable cardioverter-defibrillator implantation in the elderly.
    Yung D; Birnie D; Dorian P; Healey JS; Simpson CS; Crystal E; Krahn AD; Khaykin Y; Cameron D; Chen Z; Lee DS
    Circulation; 2013 Jun; 127(24):2383-92. PubMed ID: 23775193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of short-term complications after implantable cardioverter-defibrillator replacement: results from the Ontario ICD Database.
    Krahn AD; Lee DS; Birnie D; Healey JS; Crystal E; Dorian P; Simpson CS; Khaykin Y; Cameron D; Janmohamed A; Yee R; Austin PC; Chen Z; Hardy J; Tu JV;
    Circ Arrhythm Electrophysiol; 2011 Apr; 4(2):136-42. PubMed ID: 21325209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal trends in patient characteristics and outcomes among Medicare beneficiaries undergoing primary prevention implantable cardioverter-defibrillator placement in the United States, 2006-2010. Results from the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
    Borne RT; Peterson PN; Greenlee R; Heidenreich PA; Wang Y; Curtis JP; Tzou WS; Varosy PD; Kremers MS; Masoudi FA
    Circulation; 2014 Sep; 130(10):845-53. PubMed ID: 25095884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term benefit of primary prevention with an implantable cardioverter-defibrillator: an extended 8-year follow-up study of the Multicenter Automatic Defibrillator Implantation Trial II.
    Goldenberg I; Gillespie J; Moss AJ; Hall WJ; Klein H; McNitt S; Brown MW; Cygankiewicz I; Zareba W;
    Circulation; 2010 Sep; 122(13):1265-71. PubMed ID: 20837894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac perforation from implantable cardioverter-defibrillator lead placement: insights from the national cardiovascular data registry.
    Hsu JC; Varosy PD; Bao H; Dewland TA; Curtis JP; Marcus GM
    Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):582-90. PubMed ID: 24002030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procedure timing as a predictor of inhospital adverse outcomes from implantable cardioverter-defibrillator implantation: insights from the National Cardiovascular Data Registry.
    Hsu JC; Varosy PD; Parzynski CS; Chaudhry SI; Dewland TA; Curtis JP; Marcus GM
    Am Heart J; 2015 Jan; 169(1):45-52.e3. PubMed ID: 25497247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of diabetes mellitus on inappropriate and appropriate implantable cardioverter-defibrillator therapy and mortality in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT) Trial.
    Ruwald MH; Zareba W; Jons C; Zhang C; Ruwald AC; Olshansky B; McNitt S; Bloch Thomsen PE; Shoda M; Merkely B; Moss AJ; Kutyifa V
    Circulation; 2013 Aug; 128(7):694-701. PubMed ID: 23881862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of primary prevention implantable cardioverter-defibrillators in a population-based cohort is associated with a significant survival benefit.
    Parkash R; Sapp JL; Basta M; Doucette S; Thompson K; Gardner M; Gray C; Brownell B; Kidwai H; Cox J
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):706-13. PubMed ID: 22685111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventricular tachyarrhythmias and mortality in patients with an implantable cardioverter defibrillator: impact of depression in the MIDAS cohort.
    Mastenbroek MH; Versteeg H; Jordaens L; Theuns DA; Pedersen SS
    Psychosom Med; 2014 Jan; 76(1):58-65. PubMed ID: 24336430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reasons for and predictors of acute hospitalization versus elective outpatient implantable cardioverter-defibrillator implantation and subsequent differential clinical outcomes.
    Nishimura M; Sab S; Birgersdotter-Green U; Krummen D; Schricker A; Raissi F; Hoffmayer KS; Feld GK; Hsu JC
    J Interv Card Electrophysiol; 2017 Oct; 50(1):85-93. PubMed ID: 28844089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applicability of a risk score for prediction of the long-term (8-year) benefit of the implantable cardioverter-defibrillator.
    Barsheshet A; Moss AJ; Huang DT; McNitt S; Zareba W; Goldenberg I
    J Am Coll Cardiol; 2012 Jun; 59(23):2075-9. PubMed ID: 22651863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry.
    Dewland TA; Pellegrini CN; Wang Y; Marcus GM; Keung E; Varosy PD
    J Am Coll Cardiol; 2011 Aug; 58(10):1007-13. PubMed ID: 21867834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cardiac and noncardiac conditions on survival after defibrillator implantation.
    Lee DS; Tu JV; Austin PC; Dorian P; Yee R; Chong A; Alter DA; Laupacis A
    J Am Coll Cardiol; 2007 Jun; 49(25):2408-15. PubMed ID: 17599603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of benefit and mortality of implantable cardioverter-defibrillator therapy in patients aged ≥75 years versus those <75 years.
    Brüllmann S; Dichtl W; Paoli U; Haegeli L; Schmied C; Steffel J; Brunckhorst C; Hintringer F; Seifert B; Duru F; Wolber T
    Am J Cardiol; 2012 Mar; 109(5):712-7. PubMed ID: 22154315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effectiveness of cardiac resynchronization therapy with an implantable cardioverter-defibrillator versus defibrillator therapy alone: a cohort study.
    Masoudi FA; Mi X; Curtis LH; Peterson PN; Curtis JP; Fonarow GC; Hammill SC; Heidenreich PA; Al-Khatib SM; Piccini JP; Qualls LG; Hernandez AF
    Ann Intern Med; 2014 May; 160(9):603-11. PubMed ID: 24798523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.